e-learning
resources
Stockholm 2002
Monday 16.09.2002
Pathophysiology of exercise limitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiopulmonary exercise testing (CPET) in type 2 diabetic patients with normoalbuminuria and microalbuminuria
A. C. W. Lau, K. W. Lo, G. T. C. Leung, L. Y. C. Yam (Wanchai, Hong Kong)
Source:
Annual Congress 2002 - Pathophysiology of exercise limitation
Session:
Pathophysiology of exercise limitation
Session type:
Thematic Poster Session
Number:
1841
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. C. W. Lau, K. W. Lo, G. T. C. Leung, L. Y. C. Yam (Wanchai, Hong Kong). Cardiopulmonary exercise testing (CPET) in type 2 diabetic patients with normoalbuminuria and microalbuminuria. Eur Respir J 2002; 20: Suppl. 38, 1841
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Cardiopulmonary exercise testing responses to initial treatment in Group 1 pulmonary hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Cardiopulmonary exercise test in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 88s
Year: 2003
Cardiopulmonary exercise test in normal and overweight subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 82s
Year: 2001
Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2)
Source: Annual Congress 2010 - COPD: management
Year: 2010
Cardiopulmonary exercise testing in patients with severe pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 489s
Year: 2001
Impact of an individualized exercise training program on metabolic and aerobic capacity data of patients with type-2 diabetes mellitus: A case-control study.
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Altered exercise capacity in children with type 1 diabetes
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021
Determinants of cardio-pulmonary exercise test (CPET) and shuttle walking test (SWT) in COPD patients are different
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Study of microalbuminuria in COPD patients and its association with cardiac comorbidities
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Are spirometry indices associated with microvascular complications in type 1 diabetes subjects?
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Predicting maximal heart rate (HRMax) in patients on ß-blockers from a cardiopulmonary exercise test (CPET)
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Cardiopulmonary exercise testing (CPET) patient survey
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018
Comparison of COPD patients with and without diabetes mellitus
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept